Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Latest Japan Approvals Include Evrysdi For SMA
Plus Global First For Imeglimin
Jun 25 2021
•
By
Ian Haydock
Two New Migraine Drugs Approved In Japan • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Japan
More from Asia